Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIH 1R01DK091831)
National Heart, Lung, and Blood Institute (NIH T32HL007034)
Received: 16 November 2021
Accepted: 5 November 2022
First Online: 6 December 2022
: All study participants provided written informed consent. The study was approved by the Stanford University Human Subjects Committee and performed in accordance with the Declaration of Helsinki. This trial was prospectively registered at clinicaltrials.gov as NCT01826591 on April 8, 2013.
: Not applicable.
: The authors declare that they have no competing interests.